Search fresh public links, source activity, and ready-to-use post angles for Covid Vaccine.
Fresh curated links around Covid vaccine are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A comprehensive global review has found that mRNA vaccines aren't just highly effective at fighting infectious diseases – they are also very safe.Continue ReadingCategory:
The new vaccine is approved for adults 50 and older, with availability expected during the 2026–2027 respiratory virus season
by Gertrud U. Rey On June 18, 2026, the top advisory committee for the Food and Drug Administration (FDA) unanimously recommended Moderna’s new mRNA influenza vaccine, mRNA‑1010 (m...
In a somewhat surprise announcement, the Food and Drug Administration (FDA) has approved the first US influenza vaccine built on Moderna's mRNA technology that gave us one of...
Technology behind blockbuster Covid jabs is yielding promising results in oncology treatment
By Elise Haulund, Katherine Dillinger, Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults...
There is no evidence that COVID-19 vaccines significantly shorten life expectancy; vaccines undergo a rigorous process and clinical trials before being rolled out for public use to...
"We are hopeful that this platform could be expanded further to protect against an even wider range of respiratory viruses in the future."
The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.
The FDA approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.
Ten months on from the huge news that a chlamydia vaccine had been approved for Australia's koala population, an 18-month-old female known as Bamse ha...
Headlines are praising a new study which claims that the Covid “vaccine” reduces the risk of “Covid-related” heart attacks and strokes by 40%: A new study finds the vaccine was lin...
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
University Hospitals and Celloram are advancing Protexi, a platform that redirects antiviral immune memory from COVID-19 toward fighting tumors, with sarcoma trials planned.
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine … Source
Smaller “fractional” doses of COVID-19 booster vaccines may deliver long-lasting immunity while stretching limited supply—an approach that could lower costs and expand access durin...
,regionOfInterest=(3288,1854)&hash=2c4b3fc7645ea92ff36a8da2d66ca98d9f09fb52883fc298f69a6a0cb099cf8d)
Es hält sich das Gerücht, dass die Corona-Impfstoffe die Übersterblichkeit erhöht haben. Ein Faktencheck.
A review of billions of mRNA vaccine doses finds strong COVID protection across groups, with rare serious side effects substantially outweighed by benefits.
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab
The Food and Drug Administration (FDA) late Wednesday approved the nation's first mRNA flu vaccine, manufactured by drugmaker Moderna.
The FDA approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic,...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.